Barclays Cuts Zimmer Biomet Price Target to $118 From $125, Maintains Underweight Rating
Barclays Cuts Zimmer Biomet Price Target to $118 From $125, Maintains Underweight Rating
巴克萊銀行將Zimmer Biomet的目標股價從125美元下調至118美元，並維持減持評級
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間